Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
Crinò L, Mosconi AM, Scagliotti G, Selvaggi G, Novello S, Rinaldi M, Della Giulia M, Gridelli C, Rossi A, Calandri C, De Marinis F, Noseda M, Tonato M.
Crinò L, et al. Among authors: calandri c.
J Clin Oncol. 1999 Jul;17(7):2081-5. doi: 10.1200/JCO.1999.17.7.2081.
J Clin Oncol. 1999.
PMID: 10561261
Clinical Trial.